SMTL ID : 3qkl.1

Spirochromane Akt Inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-oligomer

Ligands

1 x SMR: N-{(2S)-3-[(3S)-8',9'-DIHYDRO-1H,3'H-SPIRO[PIPERIDINE-3,7'-PYRANO[3,2-E]INDAZOL]-1-YL]-2-HYDROXYPROPYL}-N-(2-ETHOXYETHYL)-2,6-DIMETHYLBENZENESULFONAMIDE(Non-covalent)

SMR.1: 24 residues within 4Å: Chain A: L.17, G.18, K.19, G.20, T.21, F.22, G.23, K.24, V.25, A.38, K.40, L.42, E.52, T.56, M.88, E.89, Y.90, A.91, E.95, E.139, N.140, M.142, T.152, D.153 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.25, A:A.38, A:L.42 Hydrogen bonds: A:F.22, A:G.23, A:K.40, A:E.89, A:A.91 Water bridges: A:T.21, A:K.40, A:D.153 Salt bridges: A:D.153, A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kallan, N.C. et al., Discovery and SAR of spirochromane Akt inhibitors. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-03-30

Peptides

RAC-alpha serine/threonine-protein kinase: A
GSK-3 beta peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

RAC-alpha serine/threonine-protein kinase

GSK-3 beta peptide

Related Entries With Identical Sequence